MedPath

Smoking Cessation Program Following Diagnosis of a Potentially Curable Cancer

Recruiting
Conditions
Potentially curable cancer (any type)
Cancer -
Registration Number
ACTRN12606000190505
Lead Sponsor
Peter MacCallum Cancer Centre
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

Signed informed consent- presence of a potentially curable cancer which is newly diagnosed and histologically confirmed- treatment policy established for curative intent- current smoker or recent ex smoker- ability to participate in the first interview with a quit counsellor within a week of registration- high likelihood of surviving for at least 12 months- available for 12 month follow up- ability to speak, read and write English sufficiently well- access to a telephone at home.

Exclusion Criteria

Inital treatment for cancer commenced more than two weeks prior to study registration- active current history of unstable psychiatric illness or significant cognitive deficits.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Prolonged abstience rate[At 12 months]
Secondary Outcome Measures
NameTimeMethod
Determine prolonged abstinence [At 1, 3 and 6 months];Determine point-prevalence abstinence rates [At 1, 3, 6, and 12 months];Assess associations between prolonged abstinence status at 12 months and level of nicotine dependence, demongraphic factors, type of cancer, patient readiness to abstain, distress score, quality of life, efficacy of inital anti-cancer treatment, toxicity of inital anti-cancer treatment.[];Compare quitters and non-quitters with respect to change in quality of life and distress[];Identify barriers and difficulties in the quitting process[]
© Copyright 2025. All Rights Reserved by MedPath